FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer - FDA Press Releases

FDA has approved Tukysa (tucatinib) in combination with chemotherapy for the treatment of adults with advanced forms of HER2-positive breast cancer that can’t be removed with surgery, or has spread to other parts of the body, and who have received one or more prior treatments.

from FDA Press Releases RSS Feed https://ift.tt/3bj2BP6
via IFTTT